@daviddemesquita's TRT fertility claims need context
Quick answer
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, frequently causing oligospermia or azoospermia, with semen parameter recovery taking an average of 3 to 6 months after cessation according to Liu et al. (2006, JCEM). The claim that stopping TRT for 30 to 37 days meaningfully restores sperm quality or influences offspring sex ratio through SHBG modulation is not supported by clinical trial evidence. Men on TRT seeking conception should obtain a semen analysis and consult a reproductive specialist before discontinuing therapy.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @daviddemesquita actually say?
The claim is that exogenous testosterone lowers SHBG, and low SHBG correlates with conceiving girls, while higher SHBG correlates with boys. His recommendation: stop testosterone about 30 to 37 days before trying to conceive, giving SHBG time to rise and sperm time to "load up" with male-chromosome genes.
To his credit, he hedges. He calls it "not a perfect science by any means" and frames his 30-day window as a personal wager, not a clinical protocol. That caveat matters a lot here, because the underlying science is considerably weaker than the framing suggests. He is presenting a correlation as an actionable fertility strategy, and those are very different things.
He also states the half-life of sperm is 40 days, which he uses to justify timing intercourse. The biology here is real but the logic built on top of it is shaky.
Does the science back this up?
Partially, but not in the way this video implies. The SHBG-sex-ratio link exists in the literature, but it is weak, contested, and almost certainly not something you can engineer by cycling off testosterone for a month.
The foundational study people cite is Mathews et al. (2008, PLOS ONE), which found that women with higher serum testosterone at conception were slightly more likely to have boys. A separate line of research, including work by Fukuda et al. (1996, Human Reproduction), suggested that stressful conditions, which tend to alter androgen and SHBG levels, correlated with fewer male births. Neither study was designed to test the intervention @daviddemesquita describes.
The SHBG-to-sex-ratio mechanism he is referencing is largely speculative. No randomized controlled trial has tested whether manipulating male SHBG levels by stopping TRT changes offspring sex ratio. The sperm biology here is also more complex than presented. X- and Y-bearing sperm do not differ in survivability in any clinically meaningful way under normal conditions, according to Aitken et al. (2014, Human Reproduction Update).
What did they get wrong or right?
The testosterone half-life figures are roughly accurate. Testosterone cypionate and enanthate typically clear in 14 to 21 days, and serum levels drop noticeably within 7 to 10 days of the last injection. That part checks out.
The 40-day sperm half-life figure is in the right ballpark. Spermatogenesis takes approximately 64 to 74 days in total, with sperm maturation in the epididymis adding another 12 to 21 days. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis and reduces sperm production, sometimes to azoospermia. Recovery after stopping TRT typically takes 3 to 6 months, not 30 to 37 days, based on Liu et al. (2006, Journal of Clinical Endocrinology and Metabolism).
That is the bigger problem. His 30-day window is probably too short to meaningfully restore spermatogenesis, let alone optimize it. Recommending men try to conceive 30 days after stopping TRT, when sperm counts may still be severely suppressed, could actually reduce fertility rather than improve it.
The SHBG-sex-selection mechanism is the weakest link. SHBG is primarily a female-side variable in the studies cited. Applying it to male SHBG as a sex-selection lever is a creative extrapolation, not an established pathway.
What should you actually know?
If you are on TRT and want to conceive, the fertility conversation starts much earlier than 30 days before trying. Exogenous testosterone suppresses sperm production in the majority of men, and recovery is not guaranteed within a month. A reproductive endocrinologist or urologist specializing in male fertility should be involved before you stop TRT, not after.
Medications like clomiphene citrate or human chorionic gonadotropin (hCG) are used clinically to preserve or restore fertility in men on testosterone therapy, and those conversations require a licensed provider and a semen analysis, not a TikTok timeline.
On the sex-selection question: the honest answer is that no evidence-based, non-invasive method reliably determines offspring sex. Preimplantation genetic testing during IVF is the only clinically validated approach. Everything else, including SHBG cycling, dietary changes, and timing intercourse, operates in the realm of anecdote and weak observational data.
- If fertility is your goal, get a baseline semen analysis before stopping TRT.
- Sperm recovery after TRT cessation averages 3 to 6 months, not 30 days.
- The SHBG-sex-ratio link has not been tested as a male-side intervention in any clinical trial.
- Talk to a reproductive urologist before making any changes to your TRT protocol.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @daviddemesquita's TRT fertility claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@daviddemesquita's TRT fertility claims need context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, frequently causing oligospermia or azoospermia, with semen parameter recovery taking an average of 3 to 6 months after cessation according to Liu et al.
FormBlends verdict
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, frequently causing oligospermia or azoospermia, with semen parameter recovery taking an average of 3 to 6 months after cessation according to Liu et al. (2006, JCEM). The claim that stopping TRT for 30 to 37 days meaningfully restores sperm quality or influences offspring sex ratio through SHBG modulation is not supported by clinical trial evidence. Men on TRT seeking conception should obtain a semen analysis and consult a reproductive specialist before discontinuing therapy.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, frequently causing oligospermia or azoospermia, with semen parameter recovery taking an average of 3 to 6 months after cessation according to Liu et al. (2006, JCEM). The claim that stopping TRT for 30 to 37 days meaningfully restores sperm quality or influences offspring sex ratio through SHBG modulation is not supported by clinical trial evidence. Men on TRT seeking conception should obtain a semen analysis and consult a reproductive specialist before discontinuing therapy.
- Liu et al. (2006, JCEM) found sperm recovery after testosterone suppression takes an average of 3 to 6 months, not 30 days
- Testosterone cypionate half-life is 7 to 10 days, with near-full clearance in 14 to 21 days — the video's figures are roughly correct on this point
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Liu et al. (2006, JCEM) found sperm recovery after testosterone suppression takes an average of 3 to 6 months, not 30 days
- Testosterone cypionate half-life is 7 to 10 days, with near-full clearance in 14 to 21 days — the video's figures are roughly correct on this point
- No randomized controlled trial has tested male SHBG manipulation as a sex-selection strategy — the claim is speculative
- Preimplantation genetic testing during IVF is the only clinically validated method for sex selection
- Men on TRT planning to conceive should get a baseline semen analysis before stopping therapy, not after
- hCG and clomiphene are clinically used to preserve fertility during TRT — options the video does not mention
- Azoospermia from TRT is not always reversible; men with fertility goals should discuss this risk with a reproductive urologist before starting testosterone
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
David DeMesquita™️ · TikTok creator
49.7K views on this video
Replying to @Denis Toci #fertility #boys #test #bodybuilding
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by David DeMesquita™️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.